Differential diagnosis of familial dysalbuminemic hyperthyroxinemia , RTH, and TSHomas: A single-center retrospective analysis
Endocrine · 01.04.2026 · 91 (1)
DOI: 10.1007/s12020-026-04579-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, online erschienen am 01.04.2026. Verfasst von Yuanmeng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of…. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Thyrotropin, Adenoma, Hyperthyroxinemia, Familial Dysalbuminemic. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUNDS: Familial dysalbuminemic hyperthyroxinemia (FDH) can mimic inappropriate secretion of TSH (IST) in thyroid function tests, and conventional methods may fail to detect assay interference, potentially leading to misdiagnosis as resistance to thyroid hormone (RTH) or TSH-secreting pituitary adenoma (TSHoma). METHODS: We retrospectively analyzed hospitalized patients with suspected IST over a five-year period, identifying 12 cases each of FDH and RTH, and 37 cases of TSHoma. Characteristics of genetically confirmed FDH patients and their families were summarized. Clinical and biochemical features were compared across the three groups, with cases having confounding thyroid pathology or pituitary hormone co-secretion excluded from biochemical analyses. RESULTS: A positive family history was noted in 10 of 12 FDH cases, with two patients also diagnosed with papillary thyroid carcinoma and one with Graves’ disease. The FDH group showed significantly lower median TSH, FT3, and rT3 levels, along with a higher TT4 (µg/dL)/TT3 (ng/mL) ratio compared to the RTH and TSHoma groups (all p < 0.05). ROC analysis identified optimal cutoffs for distinguishing FDH: a TT4/TT3 ratio of 10.99 for FDH vs. RTH (AUC = 0.982, 90.0% sensitivity, 100.0% specificity) and 9.94 for FDH vs. TSHoma (AUC = 1.000, 100.0% sensitivity and specificity). FT3/upper limit of normal (ULN) ratio cutoffs of 1.2 (vs. RTH, AUC = 0.905) and 1.3 (vs. TSHoma, AUC = 0.872) also showed strong discriminative value (all p < 0.01). The somatostatin analogue (SSA) test showed a stepwise increase in 24-hour/2-hour TSH suppression ratio: RTH (22.83%) < FDH (40.59%) < TSHoma (75.45%) (p < 0.001). CONCLUSIONS: FDH should be carefully considered in the differential diagnosis of IST. The TT4/TT3 and FT3/ULN ratios are useful for diagnostic discrimination. The SSA test response in FDH appears physiological and may help define a diagnostic continuum between RTH and TSHoma. These findings require validation in larger cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. LNS@…
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. LNS@medmail.com.cn.
- Department of Medical Records, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. LNS@medmail.com.cn.
ORCID-Profile: Naishi Li
Zitieren
APA
Li, Y., Zhang, K., Chai, X., Liu, H., Cheng, X., Wang, X., Chi, Y., Li, N., & Lian, X. (2026). Differential diagnosis of familial dysalbuminemic hyperthyroxinemia , RTH, and TSHomas: A single-center retrospective analysis. Endocrine, 91(1). https://doi.org/10.1007/s12020-026-04579-7
Vancouver
Li Y, Zhang K, Chai X, Liu H, Cheng X, Wang X, et al. Differential diagnosis of familial dysalbuminemic hyperthyroxinemia , RTH, and TSHomas: A single-center retrospective analysis. Endocrine. 2026;91(1). doi:10.1007/s12020-026-04579-7
BibTeX
@article{Li2026,
author = {Li, Yuanmeng and Zhang, Ke and Chai, Xiaofeng and Liu, He and Cheng, Xinqi and Wang, Xi and Chi, Yue and Li, Naishi and Lian, Xiaolan},
title = {Differential diagnosis of familial dysalbuminemic hyperthyroxinemia , RTH, and TSHomas: A single-center retrospective analysis},
journal = {Endocrine},
year = {2026},
volume = {91},
number = {1},
doi = {10.1007/s12020-026-04579-7}
}
EUVIMED